Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126931221 | 12693122 | 1 | I | 20160729 | 20160819 | 20160829 | 20160829 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54574BP | BOEHRINGER INGELHEIM | 90.68 | YR | F | Y | 0.00000 | 20160829 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126931221 | 12693122 | 1 | PS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | 75 MG | U | 559981 | 20520 | 75 | MG | TABLET | QD | ||||
126931221 | 12693122 | 2 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 0 | TABLET | /wk |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126931221 | 12693122 | 1 | Gastrooesophageal reflux disease |
126931221 | 12693122 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126931221 | 12693122 | Diarrhoea | |
126931221 | 12693122 | Incorrect drug administration duration |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126931221 | 12693122 | 1 | 20160729 | 0 |